Karlsruhe/ Weingarten (Germany), 04.07.19
Dr. Dominik Herzog, Managing Director of MicroMol GmbH announced the move in Weingarten. “We are very pleased to welcome Creamedix on board of MicroMol and Tentamus. Creamedix’ strong expertise in biocompatibility testing according to ISO 10993 of medical devices, especially its expertise in haemocompatibility testing, will allow us to offer our clients an even wider range of competences for the testing of medical devices. Due to the close geographic distance between MicroMol and Creamedix, we are pleased to develop the two companies together into a center of excellence for medical device analytics and thus further increasing the high expertise of the Tentamus laboratory network in the field of pharmaceutical and medical industry.”
Creamedix, an ISO 17025 accredited laboratory in Weingarten, Germany, analyses medical devices and raw materials on behalf of companies in the healthcare industry. Creamedix biolab’s expertise lies in biocompatibility testing according to ISO 10993 and is particularly strong in the field of in-vitro based testing systems as an alternative to animal based testing. Its services include in-vitro genotoxicity, sensitisation, irritation, and haemocompatibility testing of medical devices.
For further information visit: www.creamedix.eu